from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2506/-

LFCtreatmentdescriptionclass of inhibitor

0.059

Amikacinug/mL Amikacintranslation

-0.132

Cap5-10ug/mL Capreomycintranslation

-0.023

Rox10-50 ug/mL Roxithromycintranslation

-0.344

SM2-5 ug/mL Streptomycintranslation

1.285

Tet5-10 ug/mL Tetracyclinetranslation

0.333

Rif0.2-5ug/mL Rifampicintranscription

-0.485

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.978

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.033

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.027

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.981

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.440

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.691

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.826

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.607

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.276

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.619

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.191

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.531

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.585

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.124

Nigericin50 uM Nigericinrespiration

0.570

TRC10-150 ug/mL Triclosanrespiration

-0.737

TRZ10-25 ug/mL Thioridazinerespiration

0.621

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.339

menadione6-10 ug/mL Menadionerespiration

-0.413

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.323

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.159

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.323

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.822

NRP_1Non-replicating persistence stage 1dosRassociated

-1.079

Amp0.2mg/mL AmpicillincellWall

-0.188

Cephalexin20-100 ug/mL CephalexincellWall

-0.052

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.152

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.560

EMB10-20 ug/mL EthambutolcellWall

-0.304

Eta12-40 ug/mL EthionamidecellWall

-0.703

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.185

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.248

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.735

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.078

BZA0.12 mg/mL BenzamidearomaticAmides

-0.029

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.122

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.380

H2O24 mM hydrogen peroxideDNAdamaging

-0.479

Levo10 ug/mL LevofloxacinDNAdamaging

-0.122

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.014

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.418

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.180

UVUV-irradiationDNAdamaging

-0.078

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.811

Antimycin12.5-50 ug/mL Antimycin A?

-0.729

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.184

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.318

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.257

PA8240.2-2 ug/mL PA-824?

1.665

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.040

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.376

Verapamil50 uM Verapamil?

-0.647

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.707

methoxatin10-20 ug/mL Methoxatin?